Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2021

26.04.2021 | Images that Teach

Asymptomatic STEMI during PET stress testing: First report in a patient with heart transplant

verfasst von: Erika Hutt, Wael A. Jaber, Maan Fares

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

The prevalence of asymptomatic myocardial infarction (MI) had been reported to be 33% in large registry data, with a minority of asymptomatic MIs presenting as ST-segment elevation myocardial infarction (STEMI).1 Risk factors for asymptomatic presentation are female gender, age > 75, history of diabetes mellitus, stroke or heart failure, and history of orthotopic heart transplantation (OHT). The clinical presentation of MI in patients with OHT was first reported in 1989 by Gao et al.2 who described a high proportion of OHT recipients presenting with atypical or no symptoms of coronary artery disease (CAD). It is now known that the lack of afferent pain fibers in denervated heart allograft recipients results in a lack of angina in this population. Thus, clinicians must have a high level of suspicion for CAD in heart transplant recipients. This has led to the creation of surveillance protocols with either serial left heart catheterizations (LHC) and more recently with positron emission tomography (PET) with myocardial blood flow quantification at rest and stress. …
Literatur
1.
Zurück zum Zitat Canto JG, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000;283(24):3223–9.CrossRef Canto JG, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000;283(24):3223–9.CrossRef
2.
Zurück zum Zitat Gao SZ, et al. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 1989;64(18):1093–7.CrossRef Gao SZ, et al. Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 1989;64(18):1093–7.CrossRef
3.
Zurück zum Zitat Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy 2013;33(6):e90–5.CrossRef Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy 2013;33(6):e90–5.CrossRef
4.
Zurück zum Zitat Hsi DH, et al. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol 2013;20(3):481–4.CrossRef Hsi DH, et al. Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis. J Nucl Cardiol 2013;20(3):481–4.CrossRef
5.
Zurück zum Zitat Cavalcante JL, Barboza J, Ananthasubramaniam K. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients. J Nucl Cardiol 2011;18(4):628.CrossRef Cavalcante JL, Barboza J, Ananthasubramaniam K. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients. J Nucl Cardiol 2011;18(4):628.CrossRef
Metadaten
Titel
Asymptomatic STEMI during PET stress testing: First report in a patient with heart transplant
verfasst von
Erika Hutt
Wael A. Jaber
Maan Fares
Publikationsdatum
26.04.2021
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-021-02625-7

Weitere Artikel der Ausgabe 3/2021

Journal of Nuclear Cardiology 3/2021 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.